Frost Radar™: Clinical Documentation Integrity in North America, 2025

Healthcare Frost Radar™: Clinical Documentation Integrity in North America, 2025

A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines

INDUSTRY
Healthcare

RELEASE DATE
23-Apr-2025
REGION
North America
DELIVERABLE TYPE
Frost Radar

RESEARCH CODE
KAC4-01-00-00-00
SKU
HC_2025_33451
Yes
SHARE

$4,950.00

Special Price $4,455.00 save 10 %

In stock
SKU
HC_2025_33451

Frost Radar™: Clinical Documentation Integrity in North America, 2025
Published on: 23-Apr-2025 | SKU: HC_2025_33451

Need more details?

$4,950.00

$4,455.00 save 10 %

Need more details?

As the healthcare industry shifts from a fee-for-service to a fee-for-value model, value-based reimbursement is becoming the standard for accountable care organizations (ACOs), independent physician practices, and non-ACO entities. This transition underscores the essential role of clinical documentation integrity (CDI) specialists, medical coders, and utilization management staff in enhancing care personalization; mitigating adverse events, such as medication reconciliation errors; and improving reimbursement efficiency.

CDI, which is an integral part of revenue cycle management, is a strategic imperative in healthcare, extending beyond its role in claims processing and denials management. It enhances patient outcomes, ensures data accuracy to reflect the true care narrative, supports precise reimbursement, and strengthens compliance risk management and revenue integrity.

As new-age CDI vendors prioritize the adoption of cutting-edge technology, such as conversational AI, AI clinical assistant in medical coding, and the use of ambient AI in clinical documentation and machine learning and natural language processing in autonomous coding, it has become imperative for electronic health record-based and legacy CDI providers to stay competitive and redefine their clinical documentation tools to support next-generation workflows across the healthcare continuum.

Frost & Sullivan analyzes numerous companies in an industry. Those selected for further analysis based on their leadership or other distinctions are benchmarked across 10 Growth and Innovation criteria to reveal their position on the Frost Radar™. The publication presents competitive profiles of each company on the Frost Radar™ considering their strengths and the opportunities that best fit those strengths.

AGS Health

Amazing Charts

Arintra

Greenway Health

Iodine Software

Microsoft

Optum

Oracle Health

Provation

Solventum

Waystar

Significance of Being on the Frost Radar

CEO’s Growth Team

Investors

Customers

Board of Directors

Frost Radar™: Benchmarking Future Growth Potential 2 Major Indices, 10 Analytical Ingredients, 1 Platform

Growth Index

Growth Index (GI) is a measure of a company’s growth performance and track record, along with its ability to develop and execute a fully aligned growth strategy and vision; a robust growth pipeline system; and effective market, competitor, and end-user focused sales and marketing strategies.

  • Market Share (previous 3 years)
    This is a comparison of a company’s market share relative to its competitors in a given market space for the previous 3 years.
  • Revenue Growth (previous 3 years)
    This is a look at a company’s revenue growth rate for the previous 3 years in the market/industry/category that forms the context for the given Frost Radar™.
  • Growth Pipeline
    This is an evaluation of the strength and leverage of a company’s growth pipeline system to continuously capture, analyze, and prioritize its universe of growth opportunities.
  • Vision and Strategy
    This is an assessment of how well a company’s growth strategy is aligned with its vision. Are the investments that a company is making in new products and markets consistent with the stated vision?
  • Sales and Marketing
    This is a measure of the effectiveness of a company’s sales and marketing efforts in helping it drive demand and achieve its growth objectives.

Innovation Index

Innovation Index (II) is a measure of a company’s ability to develop products/ services/ solutions (with a clear understanding of disruptive Mega Trends) that are globally applicable, are able to evolve and expand to serve multiple markets and are aligned to customers’ changing needs.

  • INNOVATION SCALABILITY
    This determines whether an organization’s innovations are globally scalable and applicable in both developing and mature markets, and also in adjacent and non-adjacent industry verticals.
  • RESEARCH AND DEVELOPMENT
    This is a measure of the efficacy of a company’s R&D strategy, as determined by the size of its R&D investment and how it feeds the innovation pipeline.
  • PRODUCT PORTFOLIO
    This is a measure of a company’s product portfolio, focusing on the relative contribution of new products to its annual revenue.
  • MEGATRENDS LEVERAGE
    This is an assessment of a company’s proactive leverage of evolving, long-term opportunities and new business models, as the foundation of its innovation pipeline.
  • CUSTOMER ALIGNMENT
    This evaluates the applicability of a company’s products/services/solutions to current and potential customers, as well as how its innovation strategy is influenced by evolving customer needs.

Significance of Being on the Frost Radar™

Companies plotted on the Frost RadarTM are the leaders in the industry for growth, innovation, or both. They are instrumental in advancing the industry into the future.

  • GROWTH POTENTIAL
    Your organization has significant future growth potential, which makes it a Company to Action.
  • BEST PRACTICES
    Your organization is well positioned to shape Growth Pipeline™ best practices in your industry.
  • COMPETITIVE INTENSITY
    Your organization is one of the key drivers of competitive intensity in the growth environment.
  • CUSTOMER VALUE
    Your organization has demonstrated the ability to significantly enhance its customer value proposition.
  • PARTNER POTENTIAL
    Your organization is top of mind for customers, investors, value chain partners, and future talent as a significant value provider.

Have questions about this research or need deeper insights?
Speak directly with our analytics experts for tailored recommendations.

Recent related Digital Health research

26 Aug 2026   |   Global   |   Frost Radar

Frost Radar™: Healthcare Infrastructure Cybersecurity in the United States, 2026

Healthcare organizations are expanding their digital environments across cloud infrastructure, connected medical devices, applications, identities, operational technology, and distributed care settings, creating a broader and increasingly interconnected attack surface. Cybersecurity is, therefore, e...

24 Aug 2026   |   Global   |   Market Research

Growth Opportunities in Real-Time Location Systems in the Healthcare Industry, Forecast to 2031

The global healthcare RTLS market is evolving beyond traditional asset tracking toward intelligent location platforms that enable real-time visibility, workflow optimization, and operational decision-making across healthcare environments. As healthcare providers continue investing in digital transfo...

21 Aug 2026   |   Global   |   Technology Research

Innovations and Growth Opportunities in AI-Driven Biomanufacturing, Advanced Cell and Gene Therapies, and Precision Immunotherapy

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides a comprehensive overview of breakthrough innovations reshaping biomanufacturing, cell and gene therapy, precision immunotherapy, anti-infectives, and neurotherapeutics across oncology, infectious disease...

11 Aug 2026   |   Global   |   Market Research

Growth Opportunities in the Healthcare Cloud Market, Global, Forecast to 2031

The global healthcare cloud market is expanding as healthcare organizations move beyond early cloud adoption and begin to use cloud environments as a foundation for managing data, enabling interoperability, and supporting more integrated clinical and operational workflows. As adoption matures, cloud...

06 Aug 2026   |   Global   |   Technology Research

Decentralized Clinical Trials Powered by Blockchain and Digital Twins

This report examines how decentralized clinical trials (DCTs), enabled by blockchain, digital twins, and artificial intelligence, are reshaping global clinical research. It traces the shift from site-centric to patient-centric models and quantifies the growing scale, globalization, and complexity of...

 

Purchase includes:
  • Report download
  • Growth Dialog™ with our experts

Growth Dialog™

A tailored session with you where we identify the:
  • Strategic Imperatives
  • Growth Opportunities
  • Best Practices
  • Companies to Action

Impacting your company's future growth potential.

As the healthcare industry shifts from a fee-for-service to a fee-for-value model, value-based reimbursement is becoming the standard for accountable care organizations (ACOs), independent physician practices, and non-ACO entities. This transition underscores the essential role of clinical documentation integrity (CDI) specialists, medical coders, and utilization management staff in enhancing care personalization; mitigating adverse events, such as medication reconciliation errors; and improving reimbursement efficiency.

CDI, which is an integral part of revenue cycle management, is a strategic imperative in healthcare, extending beyond its role in claims processing and denials management. It enhances patient outcomes, ensures data accuracy to reflect the true care narrative, supports precise reimbursement, and strengthens compliance risk management and revenue integrity.

As new-age CDI vendors prioritize the adoption of cutting-edge technology, such as conversational AI, AI clinical assistant in medical coding, and the use of ambient AI in clinical documentation and machine learning and natural language processing in autonomous coding, it has become imperative for electronic health record-based and legacy CDI providers to stay competitive and redefine their clinical documentation tools to support next-generation workflows across the healthcare continuum.

Frost & Sullivan analyzes numerous companies in an industry. Those selected for further analysis based on their leadership or other distinctions are benchmarked across 10 Growth and Innovation criteria to reveal their position on the Frost Radar™. The publication presents competitive profiles of each company on the Frost Radar™ considering their strengths and the opportunities that best fit those strengths.
More Information
Deliverable Type Frost Radar
Industries Healthcare
No Index No
Is Prebook No
Keyword 1 Clinical documentation integrity
Keyword 2 CDI market analysis
Keyword 3 Medical coding performance
Podcast No
Predecessor None
WIP Number KAC4-01-00-00-00